These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29554021)

  • 1. Symptomatic Cerebral Sinovenous Thrombosis Associated With L-Asparaginase In Children With Acute Lymphoblastic Leukemia: A Single Institution Experience Over 17 Years.
    Malhotra P; Jain S; Kapoor G
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):e450-e453. PubMed ID: 29554021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
    Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
    Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment.
    Harlev D; Zaidman I; Sarig G; Ben Arush MW; Brenner B; Elhasid R
    Thromb Res; 2010 Aug; 126(2):93-7. PubMed ID: 20546854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management.
    Ghanem KM; Dhayni RM; Al-Aridi C; Tarek N; Tamim H; Chan AKC; Saab R; Abboud MR; El-Solh H; Muwakkit SA
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28660695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
    Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
    BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
    Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
    Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia.
    Elhasid R; Lanir N; Sharon R; Weyl Ben Arush M; Levin C; Postovsky S; Ben Barak A; Brenner B
    Blood Coagul Fibrinolysis; 2001 Jul; 12(5):367-70. PubMed ID: 11505079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe.
    Qureshi A; Mitchell C; Richards S; Vora A; Goulden N
    Br J Haematol; 2010 May; 149(3):410-3. PubMed ID: 20201945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.
    Goyal G; Bhatt VR
    Future Oncol; 2015; 11(17):2459-70. PubMed ID: 26274336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.
    Ranta S; Tuckuviene R; Mäkipernaa A; Albertsen BK; Frisk T; Tedgård U; Jónsson ÓG; Pruunsild K; Gretenkort Andersson N; Winther Gunnes M; Saulyte Trakymiene S; Frandsen T; Heyman M; Ruud E; Helgestad J
    Br J Haematol; 2015 Feb; 168(4):547-52. PubMed ID: 25288392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance.
    Yeo KK; Gaynon PS; Fu CH; Wayne AS; Sun W
    J Pediatr Hematol Oncol; 2016 Jul; 38(5):345-9. PubMed ID: 27352191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral Thrombotic Complications Related to l-Asparaginase Treatment for Acute Lymphoblastic Leukemia: Retrospective Review of 10 Cases.
    Eden D; Hipkins R; Bradbury CA
    Clin Appl Thromb Hemost; 2016 Sep; 22(6):589-93. PubMed ID: 25693917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare complication in a child undergoing chemotherapy for acute lymphoblastic leukemia: superior sagittal sinus thrombosis.
    Wang TY; Yen HJ; Hung GY; Hsieh MY; Tang RB
    J Chin Med Assoc; 2011 Apr; 74(4):183-7. PubMed ID: 21463850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
    Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
    Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of acute lymphoblastic leukemia with L-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child.
    Ucar C; Caliskan U
    Pediatr Hematol Oncol; 2006 Jun; 23(4):339-45. PubMed ID: 16621776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
    Lee JH; Lee J; Yhim HY; Oh D; Bang SM
    J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?
    Lashkari HP; Lancaster D; Atra A; Champion MP; Taj MM
    Int J Hematol; 2011 Dec; 94(6):571-5. PubMed ID: 22057510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
    Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
    Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events.
    Farrell K; Fyfe A; Allan J; Tait RC; Leach M
    Leuk Lymphoma; 2016 Nov; 57(11):2568-74. PubMed ID: 27078747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.